Lisa M Larkin
Overview
Explore the profile of Lisa M Larkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wroblewski O, Kennedy C, Vega-Soto E, Forester C, Su E, Nguyen M, et al.
Tissue Eng Part A
. 2024 Jun;
PMID: 38874526
Volumetric muscle loss (VML) is a clinical state that results in impaired skeletal muscle function. Engineered skeletal muscle can serve as a treatment for VML. Currently, large biopsies are required...
2.
Su E, Kennedy C, Vega-Soto E, Pallas B, Lukpat S, Hwang D, et al.
Tissue Eng Part A
. 2023 Dec;
30(9-10):440-453.
PMID: 38117140
Volumetric muscle loss (VML) is the loss of skeletal muscle that exceeds the muscle's self-repair mechanism and leads to permanent functional deficits. In a previous study, we demonstrated the ability...
3.
Nguyen M, Kennedy C, Wroblewski O, Su E, Hwang D, Larkin L
Tissue Eng Part A
. 2023 Oct;
30(1-2):94-101.
PMID: 37842832
Tissue engineering of exogenous skeletal muscle units (SMUs) through isolation of muscle satellite cells from muscle biopsies is a potential treatment method for acute volumetric muscle loss (VML). A current...
4.
Kennedy C, Nunez C, Poli A, Vega-Soto E, Arruda E, Larkin L
Tissue Eng Part A
. 2023 Aug;
29(17-18):471-480.
PMID: 37542392
Rotator cuff tears constitute a vast majority of shoulder-related injuries, occurring in a wide population range and increasing in incidence with age. Current treatments for full thickness tears use suture...
5.
Lee J, Becker J, Larkin L, Almarza A, Kapila S
Clin Oral Investig
. 2022 Apr;
26(7):5019-5027.
PMID: 35359187
Objective: The aim of this study was to compare and characterize the structural and ultrastructural organization of the temporomandibular joint (TMJ) between two large animal models for use in the...
6.
Rodriguez B, Novakova S, Vega-Soto E, Nutter G, Macpherson P, Larkin L
Tissue Eng Part A
. 2021 Dec;
28(13-14):606-620.
PMID: 34937425
Tissue-engineered skeletal muscle is a promising novel therapy for the treatment of volumetric muscle loss (VML). Our laboratory has developed tissue-engineered skeletal muscle units (SMUs) and engineered neural conduits (ENCs),...
7.
Wroblewski O, Nguyen M, Cederna P, Larkin L
Tissue Eng Part A
. 2021 Oct;
28(9-10):420-432.
PMID: 34652973
Tissue engineering methodologies have the potential to treat volumetric muscle loss via the growth of exogenous skeletal muscle grafts from small autogenous muscle biopsies. A significant obstacle preventing the widespread...
8.
Nutter G, VanDusen K, Florida S, Syverud B, Larkin L
Regen Eng Transl Med
. 2021 Mar;
6(4):365-372.
PMID: 33778156
Volumetric muscle loss (VML) is traumatic, degenerative, or surgical loss of skeletal muscle that exceeds the regenerative capacity of the remaining muscle, thus resulting in impaired muscle function. In humans,...
9.
Wroblewski O, Vega-Soto E, Nguyen M, Cederna P, Larkin L
Tissue Eng Part A
. 2020 Nov;
27(17-18):1151-1159.
PMID: 33203338
Skeletal muscle tissue engineering technologies have the potential to treat volumetric muscle loss (VML) by growing exogenous muscle tissue. However, there has been limited success in engineering human cell-sourced skeletal...
10.
Rodriguez B, Vega-Soto E, Kennedy C, Nguyen M, Cederna P, Larkin L
PLoS One
. 2020 Sep;
15(9):e0239152.
PMID: 32956427
Volumetric muscle loss (VML) is the loss of skeletal muscle that results in significant and persistent impairment of function. The unique characteristics of craniofacial muscle compared trunk and limb skeletal...